MP-01.01 3D Laparoscopy Is Better Than 2D in Achieving Pentafecta in Nephron-Sparing Surgery for RCC
Alexander Seregin, Russian Federation

MP-01.02 Clinical Experience and Outcomes of First 200 Uro-Oncology Cases with SSI Mantra: Single Centre Experience
Ashish Khanna, India

MP-01.03 Direct Transmesocolic Pedicle Approach for Left Laparoscopic Partial Nephrectomy
Saurav Karmakar, India

MP-01.04 Early Endoscopic Realignment of Anterior Urethra in High Grade Traumatic Urethral Injury: A Rare Case Report
Vineet Shukla, India

MP-01.05 Early Experience in Extraperitoneal Robotic Assisted Radical Prostatectomy with Novel Hugo RAS System: A Comparative Analysis with Three-Dimensional Laparoscopic Radical Prostatectomy
Miguel Marques-Monteiro, Portugal

MP-01.06 Endovascular Complication of DJ Stent
Swapnil Harne, India

MP-01.07 Enhancing Neurovascular Bundle Dissection in Robot-Assisted Radical Prostatectomy Through Intraoperative Angiography: Initial Clinical Insights
Nordine Amara, France

MP-01.08 Laparoscopic Radical Cystectomy at a High-Volume Tertiary Center: Analysis of Pentafecta Criteria and Its Relationship with Survival
Miguel Marques-Monteiro, Portugal

MP-01.09 Partial Nephrectomy on Hugo RAS Platform: Real World Experience
Aditya Pradhan, India

MP-01.10 Pathological Upstaging and Upgrading after RARP in Clinically Localized Prostate Cancer and Its Impact on Biochemical Recurrence: A Third World Country Experience
Manoj Kharade, India

MP-01.11 Percutaneous Transvesical Laparoendoscopic Single-Site Surgery (T-LESS) for Bladder Diverticulum: A Thirteen-Year Clinical Experience
Marek Roslan, Poland

MP-01.12 Pfannenstiel Incision versus Iliac Fossa Incision for Retrieval of Resected Specimen After Laparoscopic Nephrectomy: A Prospective Randomized Parallel Arm Study
Kalandi Barik, India

MP-01.13 Deceased Donor and Live Related Renal Transplantation: A Initial Single Centre Experience
Shiraz Akif Mohd Ziauddin, India

MP-01.14 Robotic Marvels in Kidney Transplants: Multi-Vessel vs Single Vessel Grafts - Our Experiences Unveiled at a Tertiary Care Centre in a Developing Nation
Shaunak Mitra, India

MP-01.15 Salvage of Short Right Renal Graft Vein Tear with Saphenous Vein: A Case Report
Navneet Saurav, India

MP-01.16 The Dual Renal Transplant: A Rare Case Report
Sachin Mohare, India

MP-01.17 The Renal Artery Injury in a Donor Nephrectomy. How We Managed It!
Sachin Mohare, India

MP-02.01 Analysis of Appendicular Interposition for Stricture Ureter
Abhinav Mallarapu, India

MP-02.02 Erection Function and Bother in Transgender Women Taking Gender Affirming Hormone Therapy and After Pre-Vaginoplasty Bilateral Orchiectomy
Maurice Garcia, United States

MP-02.03 Failed Hypospadias Repair in Adulthood: Transitional Urology
Vladimir Kojovic, Serbia

MP-02.04 Flap-Related Complications in Musculocutaneous Latissimus Dorsi Free Flap Phalloplasty
Borko Stojanovic, Serbia

MP-02.05 Identifying Stricture Urethra Using Machine Learning: A Proof of Concept Evaluation of Convolutional Neural Network Model
Udaya Lekkala, India

MP-02.06 Impact of Vaginectomy Technique on the Safety and Outcomes of Transmasculine Gender Affirming Surgery
Borko Stojanovic, Serbia

MP-02.07 Long-Term Outcomes After Surgical Repair of Peyronie's Disease
Borko Stojanovic, Serbia

MP-02.08 Mucosal Sparing Augmented Non-Transecting Urethroplasty (msANTA): Game Changer in the Management of Non Traumatic Bulbar Urethral Strictures
Sandeep Bafna, India

MP-02.09 Narcotic Free Perineal and Urethral Surgery
Tiffany Damm, United States

MP-02.10 Outcome Analysis and Management Algorithm of Obliterated Nontraumatic Urethral Strictures
Rajiv Kore, India

MP-02.11 Perineal Urethrostomy as a Feasible and Effective Urinary Diversion for the Urethral Stricture Porcine Model
Eduardo Landerer, Chile

MP-02.12 Quality of Life and Sexual Satisfaction After Metoidioplasty in Transmen
Borko Stojanovic, Serbia

MP-02.13 Specificity of Static MR-Urethrography for Assessment of Urethral Strictures Length and Spongiofibrosis Grade
Andrey Bogdanov, Russian Federation

MP-02.14 Testicular Implant Complications After Transmasculine Gender Affirming Surgery
Borko Stojanovic, Serbia

MP-02.15 The Trials and Tribulations of a Combined Uro-Plastic Clinic
Ahmad Omar, United Kingdom

MP-03.01 Anti-Inflammatory Effect of Hippophae Rhamnoides in a HCL-Induced Interstitial Cystitis/Bladder Pain Syndrome Model
Hyunsuk Yoon, Korea, Rep.

MP-03.02 The Mechanism of Big Conductance Voltage- and Ca2+-Activated K+ Channel on the Phenotypic Change of Bladder Smooth Muscle Cells Under Mechanical Stress
Qing He, China

MP-03.03 Antibacterial Prophylaxis With Fosfomycin At The Time Of The Urethral Catheter Removal After Radical Prostatectomy (Prospective Randomized Trial)
Egor Sokolov, Russian Federation

MP-03.04 Does The Brain Weep? Post Hysterectomy Leak PV May Not Always Be Urine!
Abheesh Hegde, India

MP-03.05 Features of Infection Prevention in the Surgical Intervention Area Prior to Radical Cystectomy: A Systematic Review and Meta-Analysis
Mariya Berkut, Russian Federation

MP-03.06 Flexible Cystoscopy for Recurrent Urinary Tract Infections, is it Necessary? Time To Redefine Indications
Ashwini Gaur, United Kingdom

MP-03.07 Human Herpesviruses as a Potential Etiology of Nonbacterial Chronic Cystitis and Interstitial Cystitis/Bladder Pain Syndrome
Vagan Barsegian, Russian Federation

MP-03.08 Negative Pressure Wound Treatment for Surgical Site Infection in Oncourology
Mariya Berkut, Russian Federation

MP-03.09 PD-L1 Expression in Nonbacterial Chronic Cystitis and Interstitial Cystitis/Bladder Pain Syndrome
Vagan Barsegian, Russian Federation

MP-03.10 Urologists' Take on Effectiveness, Uses & Place in Therapy of Oral Fosfomycin in Urinary Tract Infection: A Large Pan-India Survey
Prachi Kundaikar, India

MP-03.11 Hypospadias Management in Senegal: Complexity, Challenges, and Outcomes in the Urology Department of Idrissa Pouye General Hospital
Medina Ndoye, Senegal

MP-03.12 Minimally Invasive Treatment of Urinary Stones in Pediatric Population
Milan Král, Czech Republic

MP-03.13 Parental Guilt and Depression After the Child's Unilateral Orchiectomy for Torsion Testis
Swapnil Harne, India

MP-03.14 Treatment Options for Pediatric Urethral Strictures
Marko Marjanovic, Serbia

MP-03.15 Ureteroscopy in Children About 120 Cases
Mohsen Azli, Algeria

MP-04.01 Da Vincitm Vs. Hugo™ for Robot-Assisted Radical Prostatectomy: A Prospective Comparative Single-Center Study
Ricardo Brime Menendez, Spain

MP-04.02 Is Pelvic Lymph Node Dissection Necessary in Radical Prostatectomy? Results From The MICAN Study
Yuichiro Atagi, Japan

MP-04.03 Trans-Perineal Prostate Biopsy Under Local Anaesthesia With Pre-Biopsy Mpmri Scan - Way Forward In Prostate Cancer Diagnostics
Aasem Chaudry, United Kingdom

MP-04.04 A Comparative Study on the Reporting Quality of PSMA-PET in the Staging of Prostate Cancer
Thomas Li, Australia

MP-04.05 A Diagnostic Significance of Prostate Health Index (Phi)-MRI Sequence Flow in Patients with PSA Below 10ng/mL
Kazuto Ito, Japan

MP-04.06 Development and Validation of a Risk Assessment Tool to Predict Clincially Significant Prostate Cancer Among Asian Men
Peter KF Chiu, Hong Kong, China

MP-04.07 Dosing, Safety, and Pharmacokinetics of Combination Therapy with Darolutamide (DARO), Androgen-Deprivation Therapy, and Docetaxel in Patients with Metastatic Hormone-Sensitive Prostate Cancer in the ARASENS Study
Peter Hammerer, Germany

MP-04.08 Effect of Urethrovesical Anastomotic Leakage After Robotic Radical Prostatectomy on Postoperative Continence
Serdar Madendere, Türkiye

MP-04.09 Half of the Prostate Cancers Detected in South Korea During the 2010s were High-Risk Diseases; an Interim Report From a National Investigation
Young Hwii Ko, Korea, Rep.

MP-04.10 National Robotics-Assisted Radical Prostatectomy Database: A Unified Clinical-Research Model
Varsha Jevoor, Australia

MP-04.11 Preventive Effect of the Hydrogel Spacer System on Acute Proctitis After Hypofractionated Intensity-Modulated Radiotherapy for Localized Prostate Cancer
Kiichi Hagiwara, Japan

MP-04.12 Prognostic Value of MR Visibility/Invisibility in Men on Active Surveillance
Laurence Klotz, Canada

MP-04.13 Rectal Wall Infiltration with Hyaluronic Acid Based Rectal Spacer and Its Reversal
Anne Hong, Australia

MP-04.14 The Addition of Peri-Procedural Gentamicin with Ciprofloxacin Reduces Infection and Sepsis Rates Post TRUS Biopsy
Arjun Guduguntla, Australia

MP-04.15 The Role of Stockholm-3 Test in Patients Under Active Surveillance on Deciding Confirmation Biopsy
Serdar Madendere, Türkiye

MP-04.16 Weakly Supervised Deep Learning for Diagnosis of Prostate Cancer After Radical Prostatectomy: A Population-Based, Multicenter Study
Zhipeng Mai, China

MP-05.01 Surgical and Functional Outcomes of Adrenalectomy by Urologists: A 15-Year Cohort Review
Keshav Agarwal, India

MP-05.02 5-Year Review of BCG Practices and Outcome for Intermediate- and High-Risk Bladder Cancer at a Tertiary Centre
Antara Karmakar, Australia

MP-05.03 Diagnostic Value of Aquaporin 3 as a Marker of Progression of Urothelial Cancer
Valentin Pavlov, Russian Federation

MP-05.04 NSUN2 and Methyl-5-Cytosine Promote Homologous Recombination Repair via Regulating DNA:RNA Hybrid Metabolism
Yuqing Wu, China

MP-05.05 To Study Urinary Let-7c Cluster Expression as a Diagnostic Marker in Urinary Bladder Cancer
Lalit Kumar, India

MP-05.06 Enhancing Surgical Planning for Complex Renal Tumors with 3D Renal Reconstruction: A Case-Based Interactive Survey
Shashank Agrawal, India

MP-05.07 A Rare Case of Seminal Vesicle Adenocarcinoma
Archit Muralidhar, India

MP-05.08 A Scoping Review Suggests Post-Pubertal Potentially Reversible Germ Cell Atrophogenic Events Are Part of the Cause of Germ Cell Tumours and Could Justify Further Study of Testis Conservation
Tim Oliver, United Kingdom

MP-05.09 Analysis of 30-Day Complications in 300 Post-Chemotherapy RPLNDs for Testicular Germ Cell Tumors over a Decade: A Single Centre Experience
Amandeep Arora, India

MP-05.10 Assessment and Outcome of Intraoperative Frozen Section Examination of Surgical Resection Margins in the Management of Penile Cancer from a Tertiary Centre
Karl Pang, Hong Kong, China

MP-05.11 Comprehensive Assessment of Perioperative Morbidity After Retroperitoneal Lymph Node Dissection in Metastatic Germ Cell Cancer Patients Leveraging the EAU Guidelines of Standardized Complication Reporting
Jakob Klemm, Germany

MP-05.12 Impact of Scrotal Violation on Presentation and Outcomes of Patients with Non-Seminomatous Germ Cell Tumors
Amandeep Arora, India

MP-05.13 Is Histology of Retroperitoneal Lymph Node Dissection a Guide for Surgical Management of Extra Retroperitoneal Metastatic Site in Testicular Germ Cell Tumor - Implications in Clinical Practise
Amandeep Arora, India

MP-05.14 Oncological and Functional Outcomes with Nerve-Sparing Retroperitoneal Lymph Node Dissection for Testicular Non-Seminomatous Germ Cell Tumor
Mahendra Pal, India

MP-12.04 Pain And Anxiety Associated With Diagnostic Flexible Cystoscopy In A Middle Eastern Cohort.
Abdulrahman Almazeedi, Kuwait

MP-06.01 Combined Open and Endourological Management of Broken-Complex-Encrusted Forgotten Double-J Ureteral Stents Causing Renal Failure
Jaisukh Kalathia, India

MP-06.02 Could Selective Use of Single-Use Digital Flexible Ureteroscopes Reduce Annual Costs Associated with Reusable Ureteroscopes? A Local Economic Evaluation in a High-Volume Center
Francis Simard, Canada

MP-06.03 Damage Control Electrocoagulation of Arterial Bleeders in PCNL: Description of a Low Cost Modification
Harshit Rewari, India

MP-06.04 Effect of Different Irrigation Rates on Intrarenal Temperature During Laser Lithotripsy: An Experimental Study on Ex Vivo Model
Dmitry Pushkar, Russian Federation

MP-06.05 Endoscopic Stone Surgery in Patients with Bacteriuria
Dmitry Pushkar, Russian Federation

MP-06.06 How Common is Non Papillary Puncture During PCNL and Does It Have Inferior Outcome Compared to Papillary Puncture?
Bobby Viswaroop Sistla, India

MP-06.07 Inner Diameter of Narrow Ureter and Dilating Effect of Preoperative Ureteral Stent Placement
TAKAFUMI KAWAZU, Japan

MP-06.08 Optical or Visual Tract Dilatation in Percutaneous Nephrolithotomy - A New Technique with Its Safety, Efficacy Assessments
Jayaprakash Karuppaiah, India

MP-06.09 Outcomes of Percutaneous Nephrostomy in the Pregnant Cohort, in Melbourne, Australia
Yash Khanna, Australia

MP-06.10 Pharmacological Thromboprophylaxis In Percutaneous Nephrolithotomy (PCNL): A Preliminary Study
Behnam Shakiba, Iran, Islamic Rep.

MP-06.11 Postoperative Renal Functional Changes Assessed by 99mTc-DTPA Scintigraphy and Predictive Factors After Miniaturized Percutaneous Nephrolithotomy and Retrograde Intrarenal Surgery: An Observational 3-Year Follow-up Study
Hyomyoung Lee, Korea, Rep.

MP-06.12 Retrograde Intrarenal Surgery (RIRS) vs Super Mini PCNL (SMP) for Lower Pole Calyceal Calculi of 10-20 mm Size: A Randomized Controlled Trial
Niramya Pathak, India

MP-06.13 Role of Anatrophic Nephrolithotomy for Complex Staghorn Renal Calculi in the Minimally Invasive Era and Its Impact on Renal Function: A Prospective Study
Jaisukh Kalathia, India

MP-06.14 Serial Manual Bolus Irrigation Leads to Critical Intrarenal Pressures During Pyeloscopy
Anne Hong, Australia

MP-06.15 Totally Tubeless Mini-Percutaneous Nephrolitotomy Practice. How Common Are Complications?
Leo Kretzmer, United Kingdom

MP-06.16 Transurethral Pneumatic Cystolithotripsy Under Local Anaesthesia as a Day Care Procedure
Stephen Sailo, India

MVP-01.01 Emergency Robotic Exploration for Obstructed Parastomal Hernia Following Robotic Radical Cystectomy with Ileal Conduit - Our Initial Experience, Tips and Tricks
Nikhil Saurabh, India

MVP-01.02 Robot-Assisted Simple Prostatectomy: Video-Based Illustration of Modified Technique for Large Prostatic Adenoma and Its Outcomes
Swapnil Kushwaha, India

MVP-01.03 Salvage Vaginoplasty with Single-Port Robot Assisted Tubularized Urachus Peritoneal Hinge Flap: Technique Highlights, Outcomes, and an Evidence-Based Proposal for How and when to Use (and Not Use!) Peritoneum with Vaginoplasty
Maurice Garcia, United States

MVP-01.04 Transvaginal Bowel Stapling in Robotic Intraccorporeal Neobladder
Hemang Bakshi, India

MVP-01.05 Non-Transecting Non-Augmented Urethroplasty Techniques for Short Segment Bulbar Urethral Strictures
Arun Chawla, India

MVP-01.06 Robotic Augmentation Cystoplasty and Ancillary Procedure for Minimizing Morbidity and Enhancing Outcomes in Adults with Small Bladder Capacity and Incontinence After Bladder Exstrophy Reconstruction
Poojan Thakor, India

MVP-01.07 Renocolic Fistula - A Rare Complication of Obstructive Uropathy
Sofia Mesquita, Portugal

RF-01.01 Bilateral Simultaneous Robot-Assisted Redo-Pyeloplasty in Horse-Shoe Kidney Using Same-Midline Ports: Technical Appraisal
Swapnil Kushwaha, India

RF-01.02 What It is Out There: Management of a Retrovesical Mass by Robotic Approach with Technical Nuances
Qazi Imran, India

RF-01.03 Comparative Analysis Between Paclitaxel-Coated Balloon Dilatation and Direct Vision Internal Urethrotomy for Recurrent Anterior Urethral Strictures
Miguel Marques-Monteiro, Portugal

RF-01.04 Effect of Low Intensity Shock Wave Therapy in Peyronie's Disease
Parth Manek, India

RF-01.05 Complex Reconstruction in a Peculiar Case of Double Urethra with Ectopic Ureter Having Five Openings in Anal Canal
Faisal Masood Pirzada, India

RF-01.06 Penile Circular Fasciocutaneous Flap for Pananterior Urethral Stricture in Balanitis Xerotica Obliterans
Rahul Roy, India

RF-01.07 Relationship Between Testosterone Levels and the Different Causes of Urethral Stricture
David Rodriguez Canton, Spain

RF-01.08 Single Stage Repair of Classic Bladder Exstrophy - Our Experience in a Tertiary Care Centre
Rahul Roy, India

RF-01.09 Transvesical Subtrigonal Buccal Mucosal Graft Inlay for an Almost Completely Obliterated Bladder Neck Contracture: A First in the Philippines
Krizel Faustino, Philippines

RF-01.10 A Novel Classification of Aneurysmal Complication of A-V Fistula based on Site and Management Strategy: A Retrospective Study with Prospective Validation
Qazi Imran, India

RF-01.11 Impact of Renal Transplant on Erectile Dysfunction in End Stage Renal Disease Patients
Parth Manek, India

RF-01.12 Association of Heavy Metals and Trace Elements in Urolithiasis: A Case-Controlled Study
Sanjay Kumar, India

RF-01.13 The Elementome of Calcium-Based and Non-Calcium-Based Urinary Stones: A Cross-Sectional Analysis
Vaibhav Aggarwal, India

RF-01.14 Endourological Management of Urolithiasis in Transplanted Kidneys
Parth Manek, India

RF-01.15 Extracorporeal Shock Wave Lithotripsy (ESWL) for Pancreatic and Common Bile Duct (CBD) Calculi
Parth Manek, India

RF-01.16 Horrors of Forgotten DJ Stent
Sarbjit Mohapatra, India

RF-01.17 Supine Percutaneous Nephrolithotomy (PCNL) in Pediatric Patients
Parth Manek, India

The standard management of patients with MIBC is represented by neoadjuvant chemotherapy followed by radical cystectomy or chemoradiation. However, cystectomy and radical RT are associated with significant morbidity and quality of life (QoL) implications. 

Groundbreaking advances have been made in systemic therapy, making complete response to neoadjuvant treatment more frequent and treatment better tolerated and feasible. An increasing number of patients who have a remarkable response are questioning the indications to radical surgery. Critical questions are the following: can deep responders to systemic therapy keep their bladders intact?

Can neoadjuvant window of opportunity result in a bladder-sparing opportunity?

Learning Objectives

At the end of this course, attendees should:

• Increase their knowledge and the awareness on the therapeutic options to discuss with the patients once they refuse to undergo RC after neoadjuvant therapy
• Improve their flexibility to meet the patients' needs when questioning the role of radical surgery of the bladder.
• Learn how clinicians can now monitor the disease response to treatment in daily practice.
• Learn when and how a bladder-sparing approach is feasible and safe for the patients at the end of neoadjuvant therapy.

Learning Objectives

At the end of this session, attendees should be able to:

• Develop a foundational understanding of AI and its various applications in urology, including education, training, and precision medicine.
• Explore the potential of AI to enhance therapeutic approaches and patient care outcomes in uro-oncology and other urological fields.
• Identify the challenges, legal considerations, and practical implications of integrating AI into urological practices.

Learning Objectives:

At the end of this session, attendees should be able to

• Provide comprehensive counseling on the pros and cons of surveillance versus adjuvant therapy for stage I GCT
• Provide comprehensive counseling on the pros and cons of various available treatment options for stage II seminoma
• Understand limitations and future perspective regarding current and future GCT-biomarkers
• Understand the multidisciplinary management of GCT patients

Learning objectives:

At the end of this session, attendees will:

• Learn the modern preoperative and intraoperative approach to surgery for kidney Cancer.
• Have an update on the latest technologies available for renal surgery.

Learning Objectives

At the end of this session, attendees should be able to understand:

• the diagnostic and therapeutic role of en-bloc resection and enhanced assessments during TURBT in bladder cancer;
• the utility of urinary cytology and biomarkers to support diagnosis, prognosis and surveillance;
• the contemporary and future role of Artificial Intelligence (AI) the management of NMIBC. 

ESWL have been around since 1980 to treat renal calculi and most centres have at least one lithotripter. However, the usage is on a decline with the rising popularity of RIRS and PCNL, compromising the ESWL return of investment. We hope to show ways to maximize the usage of the lithotripter you have and still produce the same results as other modalities of stone treatment. We also hope to illustrate techniques to improve your ESWL outcomes in terms of stone free rates and safety.

Learning Objectives:

At the end of this session, attendees should be able to:

• Apply ESWL treatment in different stone scenario maximizing its usage           
• Apply and improve the technique of ultrasound-guided ESWL
• Acquire the knowledge to improve the success of ESWL treatment     
• Appreciate the advantages and maximize the usage of the lithotripter

Learning Objectives

At the end of this session, attendees should be able to….

• Understand the surgical and non-surgical management strategies available for locally advanced non-metastatic kidney cancer
• Be aware of the current issues and evidence available for neo-adjuvant and adjuvant treatment for locally advanced non-metastatic kidney cancer
• Understand the rationale and clinical complexities which necessitate different surgical approaches for advanced disease
• Use the knowledge of genomic syndromes to impact on clinical management
• To understand appropriate use of imaging , pathology and biomarkers in locally advanced kidney cancer.

NMIBC is a common and high burden bladder cancer state and an unmet need exists to advance treatments and maintain quality of life of patients worldwide. The IBCG Masterclass in NMIBC will review the risk classification of NMIBC, its nuances and hoe to select patients for the right approach and go over the novel treatments and strategies to allow bladder preservation for BCG-unresponsive NMIBC. We will put the discussion into context with case-based discussion with our global panelists.

Learning Objectives:

At the end of this session, attendees should be able to:

• Apply risk classification of NMIBC and how to select patients for the most appropriate treatment.
• Know about the latest advances in management of BCG unresponsive NMIBC with bladder sparing options.
• Manage toxicities of available treatments.
• Learn about treatment sequencing and maximizing the available options based on access and cost.

Learning Objectives

After this session, participants would have a better understanding of:

• The practical relevance of reducing hormone levels in ageing men,
• The role of varicocele repair in special situations like azoospermia, normozoospermia and orchalgia,
• Utility of advanced semen tests like ROS measurement.

Learning Objectives:

At the end of the session, attendees will be able to:

• Have a better understanding in clinical presentation of patients of IC/BPS
• Will have a clearer picture of Hunner’s lesion in their perception
• Will have an overall review of possible treatment modalities available 
• Will be introduced to the latest concepts in the development of science of IC/BPS including Artificial intelligence 
• Will go back with food for thought regarding new research ideas in the workplace.
• Have better knowledge in the pathology of interstitial cystitis.

Learning Objectives

At the end of the session, attendees should be able to:

• Know the current understanding of the pathophysiology of VUR and the diagnostic algorithm
• Know the role of conservative management in VUR
• Know the contributory factors to UTI, and their priority of management
• Know the indications for and role of antireflux surgery and expected outcomes
• Action points in the follow up for VUR

MP-07.01 A Comparison of Primary Gender-Affirming Vaginoplasty Outcomes: Penile Inversion versus Robotic-Assisted Peritoneal Flap
Borko Stojanovic, Serbia

MP-07.02 Cod This Be the One: Fish Skin Xenograft (Kerecis™) for Primary Gender-Affirming Vaginoplasty
Shubham Gupta, United States

MP-07.03 Comprehensive Long-Term Patient-Reported Outcomes Following Female Urogenital Fistula Repair: A 15-Year Experience from a Reconstructive Referral Center
Jakob Klemm, Germany

MP-07.04 Evaluating Long-Term Success and Patient Satisfaction: One-Stage Buccal Mucosal Graft Urethroplasty in Women
Jakob Klemm, Germany

MP-07.05 Experience of Colovaginoplasty in Adults with Disorders of Sex Development
Ismaila Mungadi, Nigeria

MP-07.06 Long Term Complications of Female Genital Mutilation and Their Surgical Management
Medina Ndoye, Senegal

MP-07.07 Not so Koi: Fish Skin Xenograft (Kerecis™) for Revision Gender-Affirming Vaginoplasty
Shubham Gupta, United States

MP-07.08 Novel Technique of Minced Buccal Mucosal Graft Endourethral Urethroplasty: A Pilot Study
Kalandi Barik, India

MP-07.09 Patient-Reported Functional Outcomes and Treatment Satisfaction Following Perinealurethrostomy in the Salvage Treatment of Complex Anterior Urethral Strictures
Jakob Klemm, Germany

MP-07.10 Positioning the Elusive Clitoris - Novel Technique to Properly Position the Neoclitoris in Transgender Women Undergoing Vaginoplasty
Maurice Garcia, United States

MP-07.11 Postauricular Skin Grafts in the Treatment of Bulbar Urethral Stricture Disease
Shoubhik Chandra, India

MP-07.12 Prospective Comparative Study of Patient Reported Outcomes of Direct Visual Internal Urethrotomy with Heinke Mikulicz Urethroplasty and Augmented Urethroplasty in Non-Traumatic Short Segment Bulbar Urethral Stricture
Arun Chawla, India

MP-07.13 Resurgence of Preputial Graft - Dorsal Onlay Single Stage Spiral Preputial Graft for Pan Urethral Strictures
Sandeep Bafna, India

MP-07.14 Surgical Correction of Penile Curvature with Autologous Graft Material
Senad Bajramovic, Bosnia And Herzegovina

MP-07.15 Urethroplasty with Autologous Ultra-Purified Adipose Graft: First Experience for Treatment of Recurrent Anterior Urethral Strictures
Elisa Berdondini, Italy

MP-07.16 Urogenital Complications of Pelvic Trauma: A Report on 48 Cases From Douala City (Cameroon)
Epoupa Ngalle Frantz Guy, Cameroon

MP-08.01 A Randomised Controlled Trial Comparing Intravesical Instillation of Cocktail vs Intravesical Injection of Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome
Niramya Pathak, India

MP-08.03 Application of Single-Layer Vaginal Flap in Transvaginal Repair for Vesicovaginal Fistula
Pu Li, China

MP-08.04 Approaches to Reduce the Risks of Mesh Exposure After Midurethral Slings: A Retrospective Long-Term Study of Erosion with a Single Type of Mesh
José Pedro Cadilhe, Portugal

MP-08.05 Autologous Fascial Slings in Women with Stress Urinary Incontinence: Systematic Review and Meta-Analysis of Randomized Controlled Trials
George Kasyan, Russian Federation

MP-08.06 Correlation of Clinical, Laboratory and Endoscopic Phenomena in Interstitial Cystitis
George Kasyan, Russian Federation

MP-08.07 Nomogram for Predicting the Presence of Hunner's Lesion
George Kasyan, Russian Federation

MP-08.08 Prospective Randomised Controlled Trial to Evaluate the Importance of Pre-Procedure Video Counselling for Patient Undergoing Invasive Urodynamic Study
Raisa Shetty, India

MP-08.09 Robotic-Assisted Mesh Sacrocolpopexy for Pelvic Organ Prolapse: Functional and QoL Outcomes with at Least 5 Years and up to 9 Years Follow-up
Vincent Tse, Australia

MP-08.10 Sexual Function in Real Life Urogynecological Practice: A Cross-Sectional Prospective Study
George Kasyan, Russian Federation

MP-08.11 Symptoms of Pelvic Floor Dysfunction in Real Life Urogynecological Practice: A Cross-Sectional Prospective Study
George Kasyan, Russian Federation

MP-08.12 Artificial Urinary Sphincter Complications and Revision Surgery: 20 Years Single Center Experience
Evgeny Ibadovich Veliev, Russian Federation

MP-08.13 Baseline Anti-Cholinergic Burden Increases Risk of Urological Complications After Antimuscarinics: A Propensity Score Matched Analysis
Alex Qinyang Liu, Hong Kong, China

MP-08.14 Comparison of Clinical and Urodynamic Characteristics of Anatomical and Functional Obstruction in Females with Nonneurogenic Voiding Dysfunction: A Single Center Experience
Atanu Kumar Pal, India

MP-08.15 Long-Term Prospective Evaluation of Patient Reported Outcome and Quality of Life in Patients with Intermittent Self Catheterization
Peter Hammerer, Germany

MP-08.16 MI-CRONS: A Novel Practical Classification for Male Urinary Incontinence
George Kasyan, Russian Federation

MP-08.17 Urinary Continence and Quality of Life After Artificial Urinary Sphincter Implantation: Long-Term Single Center Outcomes
Evgeny Ibadovich Veliev, Russian Federation

MP-09.01 Prevalence of Multimorbidity in Genitourinary Cancer in Chile: A Population-Based Study
Mario Fernandez, Chile

MP-09.02 A Genome-Wide CRISPR Screen Identified FABP5 as a Key Driver for ARSI Cross-Resistance in Prostate Cancer
Yongjiang Yu, China

MP-09.03 A Large Cohort Study of Metformin and Dipeptidyl Peptidase 4 Inhibitors for Prostate Cancer Incidence Using Japanese Claims Database
Kazushige Sakaguchi, Japan

MP-09.04 Active Surveillance in Low-Risk Prostate Cancer; the Role of Multiparametric MRI And Cancer Progression Predictors
Nasser Simforoosh, Iran, Islamic Rep.

MP-09.05 Comparative Analysis of Perioperative, Oncological and Functional Outcomes of Robotic vs Open Radical Prostatectomy for Prostates More Than 100cc
Egor Sokolov, Russian Federation

MP-09.06 Correlation of 68 Ga - PSMA PET - CT/MRI With Histopathology Characteristics in Carcinoma Prostate Patients Undergoing Radical Prostatectomy
Pratik Taur, India

MP-09.07 Cytoreductive Radical Prostatectomy in Patients with Advanced Prostate Cancer and Multiple Bone Metastases: Result of Feasibility and Local Symptoms Control
Nasser Simforoosh, Iran, Islamic Rep.

MP-09.08 Initial Experience of Radical Prostatectomy in CRPC State of Disease
Rupesh Shah, India

MP-09.09 MRI-Based Risk Calculators for High Grade Prostate Cancer Underperforms in Transperineal Prostate Biopsy in Argentinian Cohort
Gonzalo Vitagliano, Argentina

MP-09.10 Next-Generation Sequencing: The Mutational Analysis of Genes Associated with Prostate Cancer
Pankaja Umarane, India

MP-09.11 Oncological and Functional Outcomes of Hemi Ablation versus Focal Ablation for Localized Prostate Cancer Using Irreversible Electroporation (IRE)
Michel Suberville, France

MP-09.12 Predictive Factors of Locally Advanced Disease in a Cohort of Argentine Patients Undergoing Radical Prostatectomy
Gonzalo Vitagliano, Argentina

MP-09.13 Preoperative mpMRI in Surgical Planning for the Highly Aggressive Ductal Prostate Cancer
Weranja Ranasinghe, Australia

MP-09.14 Role of Focal Therapy with High-Intensity Focused Ultrasound in the Management of Clinically Localized Prostate Cancer
Dmitry Pushkar, Russian Federation

MP-09.15 - Withdrawn

MP-09.16 The Early Screening of Serum Biomarkers and the Establishment of Prediction Model for Prostate Cancer: Utilizing Artificial Intelligence-Assisted Multiplexed Nanomaterial-Assisted Laser Desorption/Ionization for Cancer Identification (MNALCI) Technique
Pengfei Zheng, China

MP-10.01 Diffusion-Weighted Magnetic Resonance Imaging for Assessment of Tumor Response in Muscle-Invasive Bladder Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Prospective Study
Abbas Basiri, Iran, Islamic Rep.

MP-10.02 Divergent Experiences of Bladder Cancer Patients: A Focus on Advanced and Metastatic Disease Stages
Alex Filicevas, Belgium

MP-10.03 Evolution of a Rapid, Simple Urine Test for Detecting Volatile Organic Compound (VOC) in Urine by a High Performance Portable Device (NABIL) for Detection of Urinary Bladder Carcinoma
Saurav Karmakar, India

MP-10.04 Intraoperative ICG Fluorescence as a Method of Prevention of Postoperative Strictures of Uretero-Ileoanastomoses During Robot-Assisted Radical Cystectomy
Valentin Pavlov, Russian Federation

MP-10.05 Intravesical Gemcitabine and Docetaxel in Patients with High Risk NMIBC: Our Experience
Deepak Krishnappa, India

MP-10.06 On Block Robot-Assisted Radical Cystectomy: New Method for Bladder Cancer
Valentin Pavlov, Russian Federation

MP-10.07 Oncological Outcomes with the 80mg Dose of the Moscow Strain of Intravesical BCG for Non-Muscle Invasive Bladder Cancer: Implications for Global Shortage
Amandeep Arora, India

MP-10.08 Outcome of Robot-Assisted Radical Cystectomy with Intracorporeal Creation of Heterotopic Neocystis
Valentin Pavlov, Russian Federation

MP-10.09 Proposed Novel Surveillance Schedule Using Cx Monitor for Patients on Annual Bladder Cancer Surveillance
Arjun Guduguntla, Australia

MP-10.10 Quality of Primary TURBTs for Non-Muscle Invasive Bladder Cancer Patients
Saurabh Verma, United Kingdom

MP-10.11 TAR-200 in Patients with Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results from the SunRISe-1 Study
Andrea Necchi, United States

MP-10.12 Timeline Analysis of Muscle Invasive Bladder Cancer Patients
Saurabh Verma, United Kingdom

MP-10.13 Transurethral Resection of Bladder Tumour (TURBT) Operative Notes: How to Improve Their Quality
Saurabh Verma, United Kingdom

MP-10.14 Trial in Progress: PIVOT-006- A Phase 3, Randomized Study of Adjuvant Intravesical Cretostimogene Grenadenorepvec versus Surveillance for the Treatment of Intermediate-Risk Non-Muscle Invasive Bladder Cancer Following Transurethral Resection of Bladder Tumor
Robert Svatek, United States

MP-10.15 URO17® Urine Test For Bladder Cancer - Meta Analysis
Nikhil Vasdev, United Kingdom

MP-10.16 Usefulness of UF-5000 Automatic Screening System in Urothelial Carcinoma Diagnosis
Tadahiko Kikugawa, Japan

MP-10.17 Validation of Novel ddPCR Bladder Cancer DNA Mutation Panels in Liquid Biopsies
Antara Karmakar, Australia

MP-11.01 Advancing Kidney Cancer Treatment: Embracing Partial Nephrectomy For T1b And T2 Tumors
Lohith S, India

MP-11.02 68Ga FAPI 4 PET CT Scan For Renal Mass Staging - Initial Experience
Rajkumar Patel, India

MP-11.03 A Wildcard For Bosniak Scoring: Role Of Contrast-Enhanced Ultrasound For Follow Up Of Bosniak 2f Cysts And Further Evaluation Of Bosniak 3 Cysts
Mohammadmehdi Adhami, Australia

MP-11.04 Clinicopathological Feature That Influence Efficacy Treated By Nivolumab Plus Ipilimumab In Patients With Metastatic Renal Cell Carcinoma
Kojiro Ohba, Japan

MP-11.05 Cutting Through Complexity: Long Term Outcomes Of IVC Resection Without Reconstruction In RCC With IVC Thrombus
Rahul Pradhan, India

MP-11.06 Da Vinci And Hugo Ras Platforms For Robot-Assisted Partial Nephrectomy: A Preliminary Prospective Comparative Analysis Of The Outcomes
Vital Hevia Palacios, Spain

MP-11.07 Do Nephrometry Scores Predict The Occurrence Of Positive Surgical Margins In Robotic Partial Nephrectomy?
Sasan Amirhassankhani, United Kingdom

MP-11.08 Does Long Warm Ischemia Time Have Always Adverse Effect On Renal Function In Post Partial Nephrectomy Patients In Long Term - What Is The Limit?
Qazi Imran, India

MP-11.09 Evaluating The Concordance Between Gross Intraoperative Evaluation Of The Tumor Bed Margin With Permanent Section Analysis In Partial Nephrectomy Patients- Preliminary Results Of A Prospective Study
Abbas Basiri, Iran, Islamic Rep.

MP-11.10 Impact Of Smoking On Postoperative Complications Following Partial Nephrectomy
Jose Nolazco, United States

MP-11.11 Incidence And Risk Factors For Urinary Fistula In Patients Undergoing Partial Nephrectomy: Results Of A Single-Center Cohort Study (Uroccr N°170)
Franck Bladou, France

MP-11.12 Is Single Layer Renorrhaphy Safe In Robotic Assisted Laparoscopic Partial Nephrectomy?
Sasan Amirhassankhani, United Kingdom

MP-11.13 Novel Nomogram Development And Internal Validation For Predicting Risk Of Pathological T3a Upstaging From Clinical T1 Mass Following Robot-Assisted Partial Nephrectomy: A Multicenter Study On The Indian Population
Shashank Agrawal, India

MP-11.14 Perioperative And Oncological Outcomes Of Robotic And Laparoscopic Nephroureterectomy As Management Option For Urothelial Carcinoma Of The Upper Tract: A Five-Year Experience From A Single-Center
Atanu Kumar Pal, India

MP-11.15 Role Of Diffusion Weighted MRI As A Diagnostic Tool For Renal Pseudotumours In Ckd Patients: A Future Way Forward
Qazi Imran, India

MP-11.16 The Role Of Tc 99m Sesta Mibi Spect CT Scan In The Characterization Of Renal Masses
TOSHIB G A, India

MP-11.17 Utility Of Contrast-Enhanced Ultrasound Compared With Conventional Imaging In The Evaluation Of Renal Masses
Mohammadmehdi Adhami, Australia

MVP-02.01 Going "Retro": a Step-by-Step Guide on Retroperitoneal Robotic Partial Nephrectomy in Complex Hilar Renal Mass
Shashank Agrawal, India

MVP-02.02 Laparoscopic/Robotic Video-Endoscopic Inguinal Lymphnode Dissection (VEIL) with Lateral Approach; Technique & Initial Experience
Rajkumar Patel, India

MVP-02.03 Supine Approach for RA-RPLND for Post Chemotherapy Residual Mass in Testicular Cancer: Video Based Illustration and Long Term Experience
Mujahid Ali, India

MVP-02.04 Straighten and Close (STAC) Repair for a Peno-Scrotal Hypospadias with Severe Chordee
Rajiv Kore, India

MVP-02.05 Ventral Onlay Buccal Mucosa Graft Urethroplasty for Female Urethral Stricture: Medium-Term Results in Our Experience
Elisa Berdondini, Italy

MVP-02.06 Robotic Right Donor Nephrectomy: Nouveau Arrival
Girish Sharma, India

RF-02.01 Innovative Role of FDG PET-CT in Assessing Systemic Therapy Response for Metastatic Renal Cell Carcinoma: Cost-Effective Evaluation in Critical Cases
Aamir Usmani, India

RF-02.02 Unveiling the Power of Diffusion-Weighted MRI: a Novel Diagnostic Approach for Distinguishing Renal Pseudotumors and RCC in CKD Patients: Advanced, Cost-Effective Innovation
Aamir Usmani, India

RF-02.03 A Rare Case of Mucinous Adenocarcinoma of Renal Pelvis Masquerading as a Non Functioning Pyonephrotic Kidney
Ashwini Kadam, India

RF-02.04 Algorithm for Management of Urolithiasis in Patients Undergoing Partial Nephrectomy for Coexistent Renal Masses-Single Center Experience
Deep Patel, India

RF-02.05 Breaking New Ground: Exploring the Diagnostic Accuracy of 99mTc MIBI Scan in Distinguishing Oncocytoma From RCC: Fulfilling Critical Needs with Innovative Precision
Aamir Usmani, India

RF-02.06 Salvage Robot-Assisted Partial Nephrectomy After Radiofrequency Ablation: Technique and Challenges Encounter
Swapnil Kushwaha, India

RF-02.07 Treatment Outcomes of Primary Genitourinary Sarcomas in a Resource Challenged Setting: Experience From a High Volume Tertiary Care Center in India
Vaibhav Aggarwal, India

RF-02.08 Bilateral Testicular Tumor as a Manifestation of Relapse in Acute Lymphoblastic Leukemia (ALL): A Case Report
Aaron Delgado, Mexico

RF-02.09 Clear Cell Sarcoma of the Penis: An Uncommon Entity with Review of the Literature
Tiffany Damm, United States

RF-02.10 'Fascia Lata First' Approach to Robot-Assisted Inguinal Lymphadenectomy-Initial Experience and Outcomes
Faisal Masood Pirzada, India

RF-02.11 Growing Teratoma Syndrome: A Case Report & Review of Literature
Lovekesh Kumar, India

RF-02.12 Effect of Androgen Deprivation Therapy on Cardiovascular Function in Patients with Advanced Prostate Carcinoma: A Prospective Cohort Study
Lovekesh Kumar, India

RF-02.13 Anterior First vs Posterior First Approach for Robot Assisted Radical Prostatectomy: A Comparative Study
Faisal Masood Pirzada, India

RF-02.14 Effects of Using Radiologic T Stage Based on Multiparametric MRI for Preoperative Risk Stratification of Localized Prostate Cancer
Miguel Marques-Monteiro, Portugal

RF-02.15 Prostate Cancer: Neoadjuvant Chemotherapy Prior to Robotic Prostatectomy - Emerging Evidence
Gaurav Sharma, United Kingdom

RF-02.16 Serum PSA Post Holmium Enucleation of the Prostate Helps Predict Future Risk of Prostate Cancer
Samuel MacDiarmid, New Zealand

Urethroplasty has become standard of care across the globe. It has been largely due to spread of knowledge through various meetings and live surgery workshops. SIU is the largest congress with international delegates. We need to update members with latest information in the field of urethral reconstruction. This course will have experts from across the continents. The course is designed to be semi live videos demonstrating various surgical techniques.

Learning Objectives

At the end of this course, attendees should be able to:

• Understand and be aware of specific challenges and controversies of some urologic reconstructive procedures that are employed in the best and effective management of complex patients.
• Recognize and identify these complex patients and outline the best pre-operative evaluation to ensure the highest treatment success rate.
• Help provide solid literature based on the best scientific level of evidence and use this knowledge to serve our patients' healthcare needs.

Around the world, transrectal prostate biopsy is gradually being replaced by transperineal (TP) biopsy due to significantly less septic complications. However, traditional TP biopsy is usually done under general or spinal anaesthesia and is associated with higher anaesthetic risk and extra resources. TP biopsy under local anaesthesia (LA) has been proven to be well tolerated. This course focuses on the basics of TP biopsy under LA and the various means that we can perform systematic and MRI-guided TP biopsies. 

Learning Objectives

At the end of this session, attendees should be able to:

• Understand the latest advances in the diagnosis (biopsy) of prostate cancer.
• Understand the benefits of transperineal prostate biopsy.
• Acquire the principles of local anaesthesia in transperineal prostate biopsy.
• Understand the various ways and platforms to perform systematic and MRI-guided targeted prostate biopsy.

Learning Objectives:

At the end of this session, attendees should be able to:

• Update the participants about current trends and management of urogenital fistula in women.
• Learn finer details about fistula management in different clinical scenarios.
• Present different surgical techniques available for treatment of urogenital fistulas and discuss their merits/demerits.
• Discuss ways of avoiding iatrogenic fistula formation in various pelvic surgeries. 

Grafts and flaps are essential armamentarium in Genitourinary Reconstruction. The objective is to teach a diverse group of audiences the basic principles of grafts and flaps, current management concepts, management of failures and complications, new frontiers and specific applications different fields of Genitourinary reconstruction.

Learning Objectives

At the end of this session, the attendees should be able:

• To know basics of grafts and flaps
• To learn various grafts and flaps in urogenital reconstruction, along with anatomy.
• To understand the causes of and management of failure of grafts and flaps
• To be familiar with new frontiers in tissue engineering
• To know about the specific application of grafts and flaps in female, pediatric groups and also in the upper tract and fistulae.

Learning Objectives

At the end of this session, attendees should be able to:

• Understand the finer points of puncture techniques in PCNL and identifying the problems and solutions.
• Strategizing the patient selection to enhance safe treatment in PCNL.
• Comprehending and optimizing the dilatation techniques in PCNL.
• Appreciating the various techniques in PCNL and selecting the right method

Learning Objectives:

At the end of this session, attendees should be able to:

• Identify who are optimal candidates for active surveillance;
• Discuss appropriate tools for monitoring patients on active surveillance;
• Integrate genomic biomarkers in the management of patients on active surveillance; and
• The use of MRI in patient selection and follow up for active surveillance; and
• Discuss the role of innocuous interventions in men on AS directed at reducing the risk of disease progression as well as overall health improvement

Learning Objectives

At the end of this session, attendees should be able to:

• Understand advancements in precision clinical staging of bladder cancer, including the roles of ctDNA, MRI, TURBT, and EUA, and how these tools contribute to more accurate diagnosis and treatment planning.
• Discuss evolving roles of radical TURBT and cisplatin-based chemotherapy, including their current place in curative strategies for bladder cancer.
• Explore optimization strategies for bladder preservation, focusing on advancements in radiotherapy and the integration of novel systemic therapies like NAC, ADC, and IO with radiation.
• Understand patient-reported outcomes (PROs) in trimodality therapy and their impact on treatment decision-making and quality of life in bladder cancer patients.

This course is designed for the experienced endoscopist who wished to perform advanced ureteroscopic procedures including complex stone presentations, multimodality therapies for upper urinary tract urothelial carcinoma, and management strategies for the obstructed upper urinary tract. The internationally recognized faculty with emphasize pre-operative preparations, various imaging modalities, evolving instrumentation and accessories, and post operative care. Strategies to increase efficiency while minimizing complications will be emphasized. Management strategies addressing peri-operative complications will also be presented.

Learning Objectives:

At the end of this session, attendees should be able to:

• Broaden understanding of ureteroscopic technique and new innovative treatments.
• Gain a comprehensive understanding of ureteroscopic lithotripsy techniques and new lithotrites.
• Able to apply advanced multimodality therapies for upper urinary tract urothelial carcinoma and upper urinary tract obstruction.
• Reinforce preventative measures and treatment stratagies for complications associated with RIRS.

POP management options can potentially include observation, conservative, and surgical options. Surgical repair involve obliterative and reconstructive procedures. Each of these has its own risks and benefits. Many urologists, urogynecologists, and pelvic reconstructive surgeons are still unaware of, or less familiar with, the role, ease and reproducibility of such treatment options for POP and associated problems. There are specific areas of POP that the literature is sparse and supported by weak evidence, especially regarding their respective best management options. Attendees should be able to identify these and foster research on them. Evidence-based guidelines supported by multi-institutional RCTs must be encouraged and become available as soon as possible for all surgeons interested in pelvic reconstruction.

Learning Objectives:

At the end of this session, attendees should:

• Understand the less known facts about pelvic organ prolapse (POP) and its associated problems (e.g., urinary incontinence, sexual dysfunction, etc.),
• Be familiar with the conservative management and the surgical techniques of POP repair,
• Understand the challenges and controversies associated with this prevalent topic,
• Decide which treatment serves best an individual patient based on the compartments involved, extent of prolapse, medical and surgical comorbidities, risks of treatment, and shared decision-making involving the patient,
• Learn (and to review) the pertinent diagnostic workup of POP, including urodynamics, imaging studies, etc.

Learning Objectives:

• Attendees will be able to understand and be aware of specific challenges and learn techniques for  urologic reconstructive procedures 
• To recognize and identify complex patients and  earn tips and tricks for reconstructive procedures.
• To help provide solid literature based on the best scientific level of evidence and use this knowledge to serve our patients’ healthcare needs

Learning Objectives

At the end of this session, attendees should be able to

• Prevent and manage sub trigonal perforation during enucleation.
• Prevent and manage Ureteric and rectal injury in transurethral resection.
• Prevent and manage large bladder perforation and Intractable bleeding in transurethral resection.
• Manage long segment bulbar urethral stricture.
• Manage Stress incontinence.